Pan-UCL symposium focusing on AAV gene therapy developments

We are extremely excited to announce the first Pan-UCL Symposium focusing on AAV gene therapy developments. This symposium will showcase the rich experience available in the various faculties at UCL, spanning vector development, preclinical studies and clinical experience. This is a full-day event with keynote UCL speakers and posters spanning the expertise available in our University.

This event is open to UCL /UCLH/GOSH staff and students, to confirm the authenticity of your registration, please use your UCL/NHS email address when registering. If you are affiliated to UCLH/GOSH please use your primary organisation's address. 

Event Programme

• 9.15am - 10:00am - Registration;
• 10.00am – 17:30pm - Talks.

Programme speakers and panellists include: Prof. Robert Brownstone, Prof. Pratima Chowdary, Dr Killian Hanlon, Prof. Gabriele Lignani, Dr Jenny McIntosh, Prof. Francesco Muntoni, Prof. Ahad Rahman and Prof. Francesco Saverio Tedesco

Talks will be followed by a Q&A panel discussion and a networking reception for in-person attendees.

This event is organized by the UCL Genetic Therapy Accelerator Centre, Institute of Neurology.

Organising Committee

Prof. Francesco Muntoni, Prof. Paul Gissen, Dr Jenny McIntosh, Dr Jo Ng, Prof. Ahad Rahim, Prof. Trevor Smart, Dr Pamela Tranter and Prof. Simon Waddington.

Poster Abstract Submission

The Pan-UCL AAV Gene Therapy Symposium invites all UCL attendees to submit up to 200-word abstract for poster presentation on the day with eligibility for the UCL AAV Symposium poster prize. The deadline for abstract submission is 3rd June 2024, with the top-scoring abstracts selected for short oral poster presentation. You will be notified by email if your abstract has been accepted by mid-June.

Please note presenters of abstracts selected for poster or oral presentation should review any confidential information/data with UCL Business if the work has not previously been declared or protected.Please note presenters of abstracts selected for poster or oral presentation should review any confidential information/data with UCL Business if the work has not previously been declared or protected.

Contact: Please email: genetictherapyaccelerator@ucl.ac.uk , If you have any questions about the event and poster abstract submission